Skip to main content

Teva’s stock and bonds plummet after Fitch downgrade to junk

Teva Pharmaceutical Industries’s stock slid 6% and its bonds dropped several points Tuesday, after Fitch Ratings downgraded the credit to junk, following disappointing earnings last week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.